CompletedPhase 1/2

Extremely Low Gestatonal Age Infants' Paracetamol Study

Finland40 participantsStarted 2018-09-03

Plain-language summary

In the present trial, early, intravenous paracetamol is compared to placebo in extremely premature or low birth weight infants in order to evaluate the effect on ductal closure.

Who can participate

Age range96 Hours

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Premature infants born before 28+0 gestation weeks and/or birth weight less than 1000g Exclusion Criteria: * Severe malformation or suspected chromosomal defect or other very severe life-threatening disease (e.g. very severe birth asphyxia or persistent pulmonary hypertension, etc.)

What they're measuring

Ductal closure

Timeframe: Neonatal intensive care unit (NICU) treatment period up to 13 weeks

Trial details

NCT IDNCT03641209

SponsorOuti Aikio

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-11-03

View on ClinicalTrials.gov More Prematurity; Extreme trials